Ajooni Biotech Limited has informed the Exchange regarding Board meeting held on July 01, 2025.
AJOONI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Ajooni Biotech Limited's Board of Directors, at a meeting held on July 1, 2025, approved the re-appointment of Mr. Jasjot Singh (DIN: 01937631) as Managing Director for a 5-year period starting FY 2025-26. His remuneration has also been revised, and the re-appointment is effective from April 1, 2025, subject to shareholder ratification at the upcoming general meeting. Mr. Singh holds an MBA in Finance from Oxford University and has over 16 years of experience in domestic and global business, finance, and taxation. He is not related to any existing directors and has not been debarred by SEBI from holding a directorship.
This is a routine leadership continuity move with no major governance red flags. Investors should watch for the shareholder vote on ratification and any further details on the revised remuneration structure, which could affect future expense ratios.